Literature DB >> 20215774

Association between a common variant near MC4R and change in body mass index develops by two weeks of age.

Clive J Petry1, Abel López-Bermejo, Marta Díaz, Giorgia Sebastiani, Ken K Ong, Francis de Zegher, David B Dunger, Lourdes Ibáñez.   

Abstract

BACKGROUND/AIMS: The common polymorphism rs17782313 lying 188 kb downstream of the MC4R gene has recently been found to be unequivocally associated with body mass index (BMI) and obesity risk in adults and children. Our objective was to test the association between rs17782313 and neonatal weight gain in a contemporary population.
METHODS: This was a cross-sectional, hospital-based study using 278 healthy Caucasian newborns [142 girls; gestational age (mean +/- SD) 39.3 +/- 1.4 weeks, birth weight 3.1 +/- 0.6 kg]. Body composition was assessed by dual-energy X-ray absorptiometry (DXA) at approximately 13 days (range 9-20) and rs17782313 was genotyped by restriction fragment length polymorphism analysis.
RESULTS: rs17782313 was not associated with weight, length or ponderal index at birth. However, it was associated with changes in BMI (p = 0.0004) over the first 2 weeks of life and with body weight (p = 0.02) and BMI (p = 0.007) at age 2 weeks. Despite this, DXA measures of fat and lean mass failed to show any simple associations.
CONCLUSION: Similar to other genetic variants associated with childhood and adult obesity, the association between rs17782313 genotype and body weight develops rapidly during the first 2 weeks of life, once caloric intake is regulated by the infant's appetite. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215774     DOI: 10.1159/000284392

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  6 in total

1.  Do gene variants influencing adult adiposity affect birth weight? A population-based study of 24 loci in 4,744 Danish individuals.

Authors:  Ehm A Andersson; Kasper Pilgaard; Charlotta Pisinger; Marie N Harder; Niels Grarup; Kristine Færch; Camilla Sandholt; Pernille Poulsen; Daniel R Witte; Torben Jørgensen; Allan Vaag; Oluf Pedersen; Torben Hansen
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

2.  Genetic and environmental influences on infant growth: prospective analysis of the Gemini twin birth cohort.

Authors:  Laura Johnson; Clare H Llewellyn; Cornelia H M van Jaarsveld; Tim J Cole; Jane Wardle
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

3.  Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics.

Authors:  Y Sterner; C Törn; H-S Lee; H Larsson; C Winkler; W McLeod; K Lynch; O Simell; A Ziegler; D Schatz; W Hagopian; M Rewers; J-X She; J P Krischer; B Akolkar; A Lernmark
Journal:  J Perinatol       Date:  2011-04-28       Impact factor: 3.225

4.  Relationships between FTO rs9939609, MC4R rs17782313, and PPARγ rs1801282 polymorphisms and the occurrence of selected metabolic and hormonal disorders in middle-aged and elderly men - a preliminary study.

Authors:  Iwona Rotter; Karolina Skonieczna-Żydecka; Danuta Kosik-Bogacka; Grażyna Adler; Aleksandra Rył; Maria Laszczyńska
Journal:  Clin Interv Aging       Date:  2016-11-23       Impact factor: 4.458

5.  Relation of FTO gene variants to fetal growth trajectories: Findings from the Southampton Women's survey.

Authors:  S J Barton; M Mosquera; J K Cleal; A S Fuller; S R Crozier; C Cooper; H M Inskip; J W Holloway; R M Lewis; K M Godfrey
Journal:  Placenta       Date:  2015-12-24       Impact factor: 3.481

6.  MC4R Variant rs17782313 Associates With Increased Levels of DNAJC27, Ghrelin, and Visfatin and Correlates With Obesity and Hypertension in a Kuwaiti Cohort.

Authors:  Maha M Hammad; Mohamed Abu-Farha; Prashantha Hebbar; Preethi Cherian; Irina Al Khairi; Motasem Melhem; Fadi Alkayal; Osama Alsmadi; Thangavel Alphonse Thanaraj; Fahd Al-Mulla; Jehad Abubaker
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-07       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.